Articoli con mandati relativi all'accesso pubblico - Richard B.Lipton, M.D.Ulteriori informazioni
Non disponibili pubblicamente: 64
Controlla
Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study
DC Buse, AN Manack, KM Fanning, D Serrano, ML Reed, CC Turkel, ...
Headache: The Journal of Head and Face Pain 52 (10), 1456-1470, 2012
Mandati: US National Institutes of Health
Controlla
Migraine: epidemiology, burden, and comorbidity
RC Burch, DC Buse, RB Lipton
Neurologic clinics 37 (4), 631-649, 2019
Mandati: US National Institutes of Health
Controlla
Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe H eadache: results of the A merican migraine prevalence and …
DC Buse, EW Loder, JA Gorman, WF Stewart, ML Reed, KM Fanning, ...
Headache: The Journal of Head and Face Pain 53 (8), 1278-1299, 2013
Mandati: US National Institutes of Health
Controlla
Post‐dural puncture headache: part I diagnosis, epidemiology, etiology, and pathophysiology
D Bezov, RB Lipton, S Ashina
Headache: The Journal of Head and Face Pain 50 (7), 1144-1152, 2010
Mandati: US National Institutes of Health
Controlla
Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial
R Croop, PJ Goadsby, DA Stock, CM Conway, M Forshaw, EG Stock, ...
The Lancet 394 (10200), 737-745, 2019
Mandati: US National Institutes of Health, National Institute for Health Research, UK
Controlla
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase …
ME Bigal, DW Dodick, AM Rapoport, SD Silberstein, Y Ma, R Yang, ...
The Lancet Neurology 14 (11), 1081-1090, 2015
Mandati: US National Institutes of Health
Controlla
Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial
R Croop, RB Lipton, D Kudrow, DA Stock, L Kamen, CM Conway, ...
The Lancet 397 (10268), 51-60, 2021
Mandati: US National Institutes of Health, National Institute for Health Research, UK
Controlla
Pathophysiology, prevention, and treatment of medication overuse headache
HC Diener, D Dodick, S Evers, D Holle, RH Jensen, RB Lipton, F Porreca, ...
The Lancet Neurology 18 (9), 891-902, 2019
Mandati: US Department of Defense, US National Institutes of Health, German Research …
Controlla
Rates, predictors, and consequences of remission from chronic migraine to episodic migraine
A Manack, DC Buse, D Serrano, CC Turkel, RB Lipton
Neurology 76 (8), 711-718, 2011
Mandati: US National Institutes of Health
Controlla
Tension-type headache
S Ashina, DD Mitsikostas, MJ Lee, N Yamani, SJ Wang, R Messina, ...
Nature Reviews Disease Primers 7 (1), 24, 2021
Mandati: US National Institutes of Health, German Research Foundation
Controlla
Trigger factors and premonitory features of migraine attacks: summary of studies
JM Pavlovic, DC Buse, CM Sollars, S Haut, RB Lipton
Headache: The Journal of Head and Face Pain 54 (10), 1670-1679, 2014
Mandati: US National Institutes of Health
Controlla
Migraine in America Symptoms and Treatment (MAST) study: baseline study methods, treatment patterns, and gender differences
RB Lipton, S Munjal, A Alam, DC Buse, KM Fanning, ML Reed, ...
Headache: The Journal of Head and Face Pain 58 (9), 1408-1426, 2018
Mandati: US National Institutes of Health
Controlla
Opioid use and dependence among persons with migraine: results of the AMPP study
DC Buse, SH Pearlman, ML Reed, D Serrano, DS Ng‐Mak, RB Lipton
Headache: The Journal of Head and Face Pain 52 (1), 18-36, 2012
Mandati: US National Institutes of Health
Controlla
Methodological issues in studying trigger factors and premonitory features of migraine
RB Lipton, JM Pavlovic, SR Haut, BM Grosberg, DC Buse
Headache: The Journal of Head and Face Pain 54 (10), 1661-1669, 2014
Mandati: US National Institutes of Health
Controlla
Predicting inadequate response to Acute Migraine Medication: results from the A merican migraine prevalence and Prevention (AMPP) Study
RB Lipton, S Munjal, DC Buse, KM Fanning, A Bennett, ML Reed
Headache: The Journal of Head and Face Pain 56 (10), 1635-1648, 2016
Mandati: US National Institutes of Health
Controlla
Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled …
RB Lipton, R Croop, DA Stock, J Madonia, M Forshaw, M Lovegren, ...
The Lancet Neurology 22 (3), 209-217, 2023
Mandati: US National Institutes of Health
Controlla
Impact of NSAID and Triptan use on developing chronic migraine: results from the a merican migraine prevalence and prevention (AMPP) study
RB Lipton, D Serrano, RA Nicholson, DC Buse, MC Runken, ML Reed
Headache: The Journal of Head and Face Pain 53 (10), 1548-1563, 2013
Mandati: US National Institutes of Health
Controlla
Identifying natural subgroups of migraine based on comorbidity and concomitant condition profiles: results of the chronic migraine epidemiology and outcomes (CaMEO) study
RB Lipton, KM Fanning, DC Buse, VT Martin, ML Reed, A Manack Adams, ...
Headache: The Journal of Head and Face Pain 58 (7), 933-947, 2018
Mandati: US National Institutes of Health
Controlla
Chronic versus episodic migraine: The 15‐day threshold does not adequately reflect substantial differences in disability across the full spectrum of headache frequency
R Ishii, TJ Schwedt, G Dumkrieger, N Lalvani, A Craven, PJ Goadsby, ...
Headache: The Journal of Head and Face Pain 61 (7), 992-1003, 2021
Mandati: US Department of Defense, US National Institutes of Health, Patient-Centered …
Controlla
Neuroticism, depression and pain perception in migraine and tension‐type headache
S Ashina, L Bendtsen, DC Buse, AC Lyngberg, RB Lipton, R Jensen
Acta Neurologica Scandinavica 136 (5), 470-476, 2017
Mandati: US National Institutes of Health
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software